MK2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK2 inhibitor, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]